This podcast was made in partnership with Allergy & Asthma Network, with funding support from AstraZeneca.
In this episode, we explore a new form of asthma treatment, Biologics. These innovative treatments offer targeted relief by addressing the underlying causes of asthma, leading to improved symptom control and a better quality of life. Dr. G and Kortney discuss the current biologics on the market for asthma treatment.
As this is a true deep dive, we have provided some more information about the Biologics discussed to help you build a better understanding. We have included images and graphs you can use when listening to the episode.
What we cover in this episode:
- A background on how Biologic treatments work.
- The Biologics available for asthma - discuss who is a candidate, how they each work, how they are taken and some side effects.
- Omalizumab (Xolair)
- Mepolizumab
- Reslizumab
- Benralizumab
- Dupilumab
- Tezepelumab
Images and graphs discussed in this episode: www.itchpodcast.com/episodes/56-asthma-biologics
A look at biologics in more depth: www.biologicmeds.org
More about type 2 inflammation: https://allergyasthmanetwork.org/news/when-asthma-more-than-asthma-type-inflammation/
The Itch: Allergies, Asthma, Eczema & Immunology näytetään tässä palvelussa avoimen RSS-syötteen kautta. RSS-syötteen tiedostot, kuvaukset, kansikuvat ja muu metadata ovat podcastin omistajan omaisuutta, eivätkä ole yhteydessä Podplayn kanssa.